Key facts
- Notable investors include MedTech Innovator, Shanghai Healthcare Capital, Frederic Moll, JIF Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for PrimaNova
- ·The full record, as it builds
Funding rounds
No funding rounds for PrimaNova are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PrimaNova
Operator and provider of a medical lab company intended to resolve critical, significant unmet medical needs in neurosurgery. The company offers advanced and transformative medtech services to overcome clinical challenges, harness capital and succeed to deliver clinical services that fundamentally change treatment paradigms, enabling patients to tackle life-threatening neuro conditions feasibly.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2020
- Website
- primanovamed.com/
- Ownership
- Privately Held (backing)
PrimaNova doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PrimaNova shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PrimaNova in its N-PORT filings yet. We sweep new filings monthly.